Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia

BACKGROUND: Ezetimibe (Zetia(®)) is a potent inhibitor of cholesterol absorption that has been approved for the treatment of hypercholesterolemia. Statin, an inhibitor of cholesterol synthesis, is the first-choice drug to reduce low-density lipoprotein-cholesterol (LDL-C) for patients with hyperchol...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Yamaoka-Tojo, Minako, Tojo, Taiki, Kosugi, Rie, Hatakeyama, Yuko, Yoshida, Yuki, Machida, Yoji, Aoyama, Naoyoshi, Masuda, Takashi, Izumi, Tohru
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2009
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2768708/
https://ncbi.nlm.nih.gov/pubmed/19821987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-511X-8-41
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller